Achieve Life Sciences Inc. will host in-person one-on-one meetings during the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, taking place from January 12-15, 2026. The company's CEO, Rick Stewart, and other senior management members will provide an overview of Achieve's late-stage cytisinicline program for smoking and vaping cessation and discuss plans for the upcoming year.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL50252) on December 17, 2025, and is solely responsible for the information contained therein.
Comments